Table 2. Immunization status of confirmed measles cases, by age group and completeness1, Canada, 2015.
Age group | Not Immunized | Immunized | Unknown | |||
---|---|---|---|---|---|---|
Not up-to-date | Up-to-date | Not up-to-date | Up-to-date | Unable to assess | Up-to-date | |
<1 year | 0 | 5 | 0 | 0 | 0 | 0 |
1 to 4 years | 17 | 0 | 0 | 1 | 0 | 0 |
5 to 9 years | 35 | 0 | 0 | 0 | 0 | 0 |
10 to 14 years | 51 | 0 | 4 | 0 | 0 | 0 |
15 to 19 years | 33 | 0 | 1 | 4 | 1 | 0 |
20 to 24 years | 14 | 0 | 0 | 1 | 0 | 0 |
25 to 29 years | 8 | 0 | 0 | 0 | 0 | 0 |
30 to 39 years | 5 | 0 | 3 | 1 | 5 | 0 |
40 to 59 years | 0 | 2 | 1 | 0 | 2 | 2 |
60 years or more | 0 | 0 | 0 | 0 | 0 | 0 |
TOTAL | 163 | 7 | 9 | 7 | 8 | 2 |
1 The current recommendation for routine immunization by NACI is that the first dose of measles-containing vaccine should be given at 12 to 15 months of age, with the second dose at 18 months, or any time thereafter prior to school entry (16). Age groups where there is no existing recommendation are considered up-to-date for age having received no doses of measles-containing vaccine. This includes infants less than one year of age, who are too young to receive measles-containing vaccine as part of the routine schedule. There is also no recommendation for most adults born before 1970, as they are generally presumed to be immune to measles through prior infection.